Brooke-Spiegler syndrome: An heterogeneous entity;Síndrome de Brooke-Spiegler: Una entidad heterogénea

Actas Dermo-Sifiliograficas

Volumn 97, Issue 10, 2006, Pages 669-672

  Mataix, Javier ^a   Banuls J ^a   Botella, R ^a   Laredo, C ^a   Lucas, A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Brooke Spiegler syndrome; Cylindromas; Spiradenomas; Trichoepitheliomas

Indexed keywords

ADULT; ARTICLE; BROOKE SYNDROME; CASE REPORT; CLINICAL FEATURE; CYLINDROMA; FEMALE; GENE MUTATION; GENODERMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PHENOTYPE; SCHOOL CHILD; SKIN BIOPSY;

EID: 33846324304     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(06)73492-5     Document Type: Article

References (30)

1. Szepietowski JC, Wasik F, Szybejko-Machaj G, Bieniek A, Schwartz RA. Brooke-Spiegler syndrome. J Eur Acad Dermatol Venereol. 2001;15:346-9.
2. Ly H, Black MM, Robson A. Case of the Brooke-Spiegler syndrome. Australas J Dermatol. 2003;44:144-8.
3. Lee DA, Grossman ME, Schneiderman P, Celebi JT. Genetics of skin appendage neoplasms and related syndromes. J Med Genet. 2005;42:811-9.
4. Carsuzza F, Carloz E, Lebeuf M, Grob JJ, Arnoux D. Multiple trichoepithelioma, cylindroma, miliaria and carcinomatous transformation. Ann Dermatol Venereol. 1992; 119:746-8.
5. Johnson SC, Bennet RG. Ocurrence of basal cell carcinoma among multiple trichoepitheliomas. J Am Acad Dermatol. 1993;28:322-6.
6. Uede K, Yamamoto Y, Furukawa F. Brooke-Spiegler syndrome associated with cylindroma, trichoepithelioma, spiradenoma, and syringoma. J Dermatol. 2004;31:32-8.
7. Biggs PJ, Wooster R, Ford D, Chapman P, Mangion J, Quirk Y, et al. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene. Nat Genet. 1995;11:441-3.
8. Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet. 2000;25:160-5.
9. Trompouki E, Hatzivassiliou E, Tsichritzs T, Farmer H, Ashworth A, Mosialos G, et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature. 2003;424:793-6.
10. Schmidt-Ullrich R, Aebischer T, Hulsken J, Birchmeier W, Klemm U, Scheidereit C, et al. Requirement of NF-kappaB/rel for the development of hair follicles and other epidermal appendices. Development. 2001;128:3843-53.
11. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature. 2003;424: 797-801.
12. Massouni R, Chmielarska K, Hennecke K, Pfeifer A, Fassler R. Cyld inhibits tumor cell proliferation by blocking bcl-3-dependent NF-kappaB signalling. Cell. 2006:125:665-77.
13. Zhang XJ, Liang YH, He PP, Yang S, Wang HY, Chen JJ, et al. Identification of the cylindromatosis tumor-suppressor gene responsible for multiple familial trichoepithelioma. J Invest Dermatol. 2004;122:658-64.
14. Zheng G, Hu L, Huang W, Chen K, Zhang X, Yang S, et al. CYLD mutation causes multiple familial trichoepithelioma in three Chinese families. Hum Mutat. 2004;23:400.
15. Bowen S, Gill M, Lee DA, Fisher G, Geronemus RG, Vazquez ME, et al. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation. J Invest Dermatol. 2005;124:919-20.
16. Gerretsen AL, Beemer FA, Deenstra W, Hennekam FA, van Vloten WA. Familiar cutaneous cylindromas: Investigations in five generations of a family. J Am Acad Dermatol. 1995;33:199-206.
17. Saunders H, Tucker P, Saurine T, Watkins F. Pedigree of multiple benign adnexal tumours of Brooke-Spiegler type. Australas J Dermatol. 2003;44:144-8.
18. Poblete-Gutiérrez P, Eggermann T, Holler D, Jugert FK, Beermann T, Grussendorf-Conen EI, et al. Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. J Invest Dermatol. 2002;119:527-31.
19. Fenske C, Banerjee P, Holden C, Carter N. Brooke-Spiegler syndrome locus assigned to 16q12-913. J Invest Derm. 2000;114:1057-8.
20. Angulo J, González-Guerra E, Vargas-Machuca I, Fariña MC, Martín L, Requena L. Espiradenomas múltiples con distribución lineal. Actas Dermosifiliogr. 2006;97:31-4.
21. Gerretsen A, van der Putte S, Deenstra W. Cutaneous cylindroma with malignant transformation. Cancer. 1993;72: 1618-23.
22. Ishikawa M, Nakanishi Y, Yamakazi N, Yamamoto A. Malignant eccrine spiradenoma: a case report and review the literature. Dermatol Surg. 2001;27:67-70.
23. Jungehulsing M, Wagner M, Damm M. Turban tumour with involvement of the parotid gland. J Laryngol Otol. 1999;113:779-83.
24. Goette DK, McConnel MA, Fowler VR. Cylindroma and eccrine spiradenoma coexistent in the same lesion. Arch Dermatol. 1982;118:723-4.
25. Borrego-Hernando L, Pinedo-Moraleda F, Rivera-Díaz R, Domínguez-Franjo P, López-Estebaranz JL. Tricoepitelioma múltiple familiar asociado a cilindroma y espiradenoma. Síndrome de Brooke-Spiegler. Actas Dermosifiliogr. 2002;93:254-8.
26. Weyers W, Nilles M, Eckert F, Schill WB. Spiradenomas in Brooke-Spiegler syndrome. Am J Dermatopathol. 1993;15: 156-61.
27. Schirren CG, Worle B, Kind P, Plewig G. A nevoid plaque with histological changes of trichoepithelioma and cylindroma in Brooke-Spiegler syndrome. An immunohistochemical study with cytokeratins. J Cutan Pathol. 1995;22: 563-9.
28. Ly H, Black MM, Robson A. Case of the Brooke-Spiegler syndrome. Australas J Dermatol. 2004;45:220-2.
29. Rallan D, Harland CC. Brooke-Spiegler syndrome: treatment with laser ablation. Clin Exp Dermatol. 2005;30: 355-7.
30. Oosterkamp HM, Neering H, Nijman SM, Dirac AM, Mooi WJ, Bernards R, et al. An evaluation of the efficacy of topical application of salicylic acid for the treatment of familial cylindromatosis. Br J Dermatol. 2006;155:182-5.